Over the last 7 days, the Pharma industry has remained flat, although notably Bristol-Myers Squibb declined by 4.5%. As for the the longer term, the industry is up 22% over the past 12 months. Earnings are forecast to grow by 27% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 08 Jul 2024 | US$2.0t | US$357.6b | US$13.8b | 15.1x | 141.8x | 5.5x |
Wed, 05 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 15.3x | 135.5x | 5.3x |
Fri, 03 May 2024 | US$1.9t | US$361.6b | US$16.3b | 22.2x | 113.9x | 5.1x |
Sun, 31 Mar 2024 | US$1.9t | US$355.2b | US$22.6b | 22.7x | 84.4x | 5.4x |
Tue, 27 Feb 2024 | US$1.9t | US$355.2b | US$23.9b | 24.2x | 80x | 5.4x |
Thu, 25 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 25.9x | 51.9x | 4.7x |
Sat, 23 Dec 2023 | US$1.7t | US$375.2b | US$33.9b | 26.7x | 49.3x | 4.4x |
Mon, 20 Nov 2023 | US$1.6t | US$375.1b | US$34.0b | 25.8x | 48.1x | 4.4x |
Wed, 18 Oct 2023 | US$1.7t | US$381.8b | US$43.8b | 18.3x | 39.2x | 4.5x |
Fri, 15 Sep 2023 | US$1.8t | US$381.8b | US$43.9b | 18x | 39.9x | 4.6x |
Sun, 13 Aug 2023 | US$1.8t | US$381.5b | US$43.9b | 18.7x | 40.2x | 4.6x |
Tue, 11 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 19.1x | 27.8x | 4.3x |
Thu, 08 Jun 2023 | US$1.7t | US$393.0b | US$60.5b | 18.7x | 28.3x | 4.4x |
Sat, 06 May 2023 | US$1.7t | US$393.0b | US$59.5b | 19.4x | 28.8x | 4.4x |
Mon, 03 Apr 2023 | US$1.6t | US$401.2b | US$69.4b | 16.1x | 22.8x | 3.9x |
Wed, 01 Mar 2023 | US$1.5t | US$401.4b | US$69.6b | 17.6x | 22.2x | 3.9x |
Fri, 27 Jan 2023 | US$1.7t | US$402.6b | US$69.4b | 17.6x | 24.2x | 4.2x |
Sun, 25 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.8x | 24.8x | 4.4x |
Tue, 22 Nov 2022 | US$1.7t | US$403.7b | US$71.1b | 13x | 24.3x | 4.3x |
Thu, 20 Oct 2022 | US$1.6t | US$403.4b | US$72.1b | 12.8x | 22x | 3.9x |
Sat, 17 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 13.8x | 22.3x | 3.9x |
Mon, 15 Aug 2022 | US$1.7t | US$403.0b | US$70.3b | 15.1x | 23.5x | 4.1x |
Wed, 13 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 21.8x | 25.8x | 4.3x |
Fri, 10 Jun 2022 | US$1.6t | US$392.5b | US$64.7b | 20.7x | 25.3x | 4.2x |
Sun, 08 May 2022 | US$1.6t | US$392.7b | US$62.9b | 20.5x | 25.9x | 4.1x |
Tue, 05 Apr 2022 | US$1.6t | US$373.8b | US$60.3b | 20.9x | 27.3x | 4.4x |
Thu, 03 Mar 2022 | US$1.5t | US$373.7b | US$60.4b | 21x | 25.5x | 4.1x |
Sat, 29 Jan 2022 | US$1.6t | US$363.7b | US$40.7b | 21.9x | 39.1x | 4.4x |
Mon, 27 Dec 2021 | US$1.7t | US$361.1b | US$37.9b | 22.6x | 43.7x | 4.6x |
Wed, 24 Nov 2021 | US$1.6t | US$360.7b | US$38.2b | 23.7x | 41.4x | 4.4x |
Fri, 22 Oct 2021 | US$1.5t | US$340.0b | US$24.9b | 20.7x | 61.1x | 4.5x |
Sun, 19 Sep 2021 | US$1.5t | US$337.6b | US$25.9b | 22.9x | 57.7x | 4.4x |
Tue, 17 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 19.9x | 63.4x | 4.8x |
61.1x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 1.70% | |
Healthcare | -0.44% | |
Pharma | -0.36% | |
Pharma | -0.36% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ZTS Zoetis | US$174.96 | 1.4% +US$1.1b | 2.8% | PE33.4x | |
LLY Eli Lilly | US$914.57 | 0.02% +US$180.1m | 101.8% | PE134.2x | |
ITCI Intra-Cellular Therapies | US$69.56 | 2.3% +US$165.8m | 14.1% | PS14.3x | |
LBPH Longboard Pharmaceuticals | US$34.87 | 12.8% +US$153.6m | 378.3% | PB4.3x | |
CTLT Catalent | US$56.73 | 1.0% +US$103.2m | 24.5% | PS2.5x |